Pharmacology of leukotriene receptor antagonists

American Journal of Respiratory and Critical Care Medicine

Volumn 157, Issue 6 II SUPPL., 1998, Pages

  Aharony, David ^a,b  

^a Zeneca Pharmaceuticals   (United States)

^b ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 [2 METHOXY 4 [(PHENYLSULFONYLAMINO)CARBONYL]BENZYL] 1H INDAZOLE 6 CARBAMIC ACID CYCLOPENTYL ESTER; 5 ETHYL 2 HYDROXY 4 [6 METHYL 6 (1H TETRAZOL 5 YL)HEPTYLOXY]ACETOPHENONE; 7 [3 (4 ACETYL 3 HYDROXY 2 PROPYLPHENOXY) 2 HYDROXYPROPOXY] 4 OXO 8 PROPYL 4H 1 BENZOPYRAN 2 CARBOXYLIC ACID; APAFANT; DEXAMETHASONE; INDOMETACIN; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MEPYRAMINE; MONTELUKAST; OVALBUMIN; PEPTIDOLEUKOTRIENE; PLACEBO; POBILUKAST; PRANLUKAST; PROPRANOLOL; TOMELUKAST; TRITIUM; UNCLASSIFIED DRUG; ZAFIRLUKAST;

ALLERGIC RHINITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ASTHMA; BINDING AFFINITY; BRONCHOSPASM; CELL MEMBRANE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; EOSINOPHILIA; GUINEA PIG; HUMAN; HUMAN CELL; INFLAMMATION; INHALATIONAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG ALVEOLUS CELL; LUNG COMPLIANCE; LUNG RESISTANCE; NONHUMAN; ORAL DRUG ADMINISTRATION; PNEUMONIA; PRIORITY JOURNAL; REVIEW;

EID: 0031777089     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.157.6.mar-2     Document Type: Review

References (14)

1. Coleman, R. A., R. M. Eglen, R. L. Jones, S. Narumiya, T. Shimizu, W. L. Smith, S.-E. Dahlén, J. M. Drazen, P. J. Gardiner, W. T. Jackson, T. R. Jones, R. D. Krell, and S. Nicosia. 1995. Prostanoid and leukotriene receptors: a progress report from the IUPHAR working parties on classification and nomenclature. Adv. Prostaglandin Thromboxane Leukot. Res. 23:283-285.
2. Torphy, P. J., I. Faiferman, J. G. Gleason, R. F. Hall, M. A. Lewis, C. Broom, H. M. Helfrich, J. F. Newton, and D. W. P. Hay. 1991. The preclinical and clinical pharmacology of SK&F 104353, a potent and selective peptidoleukotriene receptor antagonist. Ann. N.Y. Acad. Sci. 629:157-167.
3. Aharony, D., and R. D. Krell. 1991. Pharmacology of peptide leukotriene receptor antagonists. Ann. N. Y. Acad. Sci. 629:125-132.
4. 3H-ICI 198,615 to receptors on human lung membranes. In U. Zor, Z. Naor, and A. Danon, editors. Leukotrienes and Prostanoids in Health and Disease, Vol 3: New Trends in Lipid Mediator Research. Karger, Basel. 67-71.
5. Barnes, N. C., and J. C. Pujet. 1997. Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthma. Thorax 52:523-527.
6. Krell, R. D., D. Aharony, C. K. Buckner, R. A. Keith, E. J. Kusner, D. W. Snyder, P. R. Bernstein, V. G. Matassa, Y. K. Yee, F. J. Brown, B. Heasp, and R. A. Giles. 1990. The preclinical pharmacology of ICI 204,219: a peptide leukotriene antagonist. Am. Rev. Respir. Dis. 141:978-987.
7. 4 receptor antagonist. Can. J. Fhysiol. Pharmacol. 73:191-201.
8. Obata, T., Y. Okada, M. Motoishu, N. Nakagawa, T. Terawaki, and H. Aishita. 1992. In vitro antagonism of ONO-1078, a newly developed anti-asthma agent, against peptide leukotrienes in isolated guinea pig tissues. Jpn. J. Pharmacol. 60:227-237.
9. Nakagawa, N., T. Obata, T. Kobayashi, Y. Okada, F. Nambu, T. Terawaki, and H. Aishita. 1992. In vivo pharmacologic profile of ONO-1078: a potent, selective, and orally active peptide leukotriene (LT) antagonist. Jpn. J. Pharmacol. 60:217-225.
10. Nakagawa, N., T. Obata, T. Kobayashi, Y. Okada, F. Nambu, T. Terawaki, T. Furuya, K. Muryobayashi, M. Sawada, and H. Aishita. 1993. Effect of a peptide leukotriene receptor antagonist, ONO-1078, on guinea-pig models of asthma. Eur. J. Pharmacol. 235:211-219.
11. Abraham, W. M. 1996. The sheep as a model of the late asthmatic response. In D. Raeburn and M. A. Giembycz, editors. Airways Smooth Muscle: Modeling the Asthmatic Response In Vivo. Birkhauser Verlag, Basel. 171-189.
12. Abraham, W. M., A. Ahmed, A. Cortes, M. Sielczak, and J. Hallmon. 1993. The effects of a cysteinyl leukotriene antagonist (ONO-1078) on antigen-induced responses in allergic sheep. Prostaglandins Leukot. Esscnt. Fatty Acids 48:233-239.
13. Krell, R. D., C. J. Dehaas, D. J. Lengel, E. J. Kusner, J. C. Williams, and C. K. Buckner. 1994. Preclinical exploration of the potential antiinflammatory properties of the peptide leukotriene antagonist ICI 204,219 (Accolate™). Ann. N.Y. Acad. Sci. 744:289-298.
14. 4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody. Am. J. Respir. Crit. Care Med. 154:850-857.